Richard A. Edlin Eagle Pharmaceuticals, Inc. (EGRX) insider trading activity
Richard A. Edlin is Director of EAGLE PHARMACEUTICALS, INC.. Currently has a direct ownership of 22,600 shares of EGRX, which is worth approximately $13,560. The most recent transaction as insider was on Sep 06, 2022, when has been sold 6,800 shares (Common Stock) at a price of $30.99 per share, resulting in proceeds of $210,732. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
22.6K
0%
3M change
0%
12M change
Total Value Held
$13,560
RAE
Richard A. Edlin
Director
Woodcliff Lake, NJ